Semaglutide in spinal cord injury and diabetic subjects
Lay Description
This study well measure the effectiveness of semaglutide on insulin sensitivity, body weight and fat/lean mass in subjects spinal cord injuries and diabetes
Category
- Diabetes
- IRB Number
- STUDY00000591
- NCT Number
- NCT06706284
Eligibility
- Eligible Ages
- 18-70
- Eligible Genders
- all
- Accepts Healthy Volunteers
- No
Inclusion Criteria
spinal cord injury (greater than 1 year post SCI)
type 2 diabetes (BMI >22kg/m2)
Exclusion Criteria
older than 70
pregnant
Study Design
Arm Groups
Study Contact
Andrea Hansis-Diarte
210-567-3208
hansisdiarte@uthscsa.edu
Mooney Mark-Johnson
210 450 8696
markjohnson@uthscsa.edu
Mooney Mark-Johnson
210 450 8696
markjohnson@uthscsa.edu
Jessica Pena
penaj21@uthscsa.edu
Noelle Vinson
832-856-1520
vinsonn@uthscsa.edu
Principal Investigator
Marzieh Salehi